Korea University Anam Hospital
Seoul, South Korea
Location status: Recruiting
Location contact
Mi-Na Kim
SUB_INVESTIGATOR
Seong-Mi Park
PRINCIPAL_INVESTIGATOR
So Ree Kim
SUB_INVESTIGATOR
So Ree Kim, MD
CONTACT
NCT Number: NCT04822649
The correlation of coronary microvascular function and body composition with cardiopulmonary exercise capacity will be assessed in patients with heart failure with preserved ejection fraction.
Interested in participating?
Request Info20 year–80 year
All sexes
Interventional
Not applicable
Seoul, South Korea
Location status: Recruiting
Mi-Na Kim
SUB_INVESTIGATOR
Seong-Mi Park
PRINCIPAL_INVESTIGATOR
So Ree Kim
SUB_INVESTIGATOR
So Ree Kim, MD
CONTACT
We will select the patients with chest pain or ischemic symptoms with non-obstructive coronary artery disease (<50% stenosis) in coronary angiography and preserved ejection fraction (≥50%) in echocardiography. All patients will undergo body composition analysis and adenosine stress echocardiography with the evaluation of coronary artery blood flow by Doppler echocardiography and maximal oxygen consumption (VO2 max) by cardiopulmonary exercise test (CPET). Left ventricular end-diastolic pressure will be assessed during coronary angiography. Coronary flow reserve (CFR) is defined as the ratio of peak to baseline mean diastolic velocity of coronary blood flow. The correlation of CFR and body composition with cardiopulmonary exercise capacity will be assessed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The color Doppler flow of distal left anterior descending artery will be examined from the modified apical four-chamber view in the anterior interventricular groove.
In regard to body composition analysis, Using InBody S10, impedance is measured in 6 frequency bands (1 kilohertz (kHz), 5 kHz, 50 kHz, 250 kHz, 500 kHz, 1000 kHz) for each of 5 parts (right plate, left arm, torso, right leg, left leg). Reactance is measured in 3 frequency bands (5 kHz, 50 kHz, 250 kHz for each of 5 parts (right arm, left arm, torso, right leg, left leg).
By treadmill exercise test with modified Bruce protocol or bicycle ergometer for patients with orthopedic problems, maximal oxygen consumption (VO2 max) will be measured using the exhalation gas analysis.
Other names: Body composition analysis, Cardiopulmonary exercise test
Time frame: up to day 14
Coronary blood flow is assessed by coronary flow reserve (CFR), which is defined as peak to baseline mean diastolic velocity of coronary flow.
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.
Time frame: up to day 14
In body composition analysis, skeletal muscle mass and body fat mass will be assessed.
In regard to cardiopulmonary exercise capacity, maximal oxygen consumption (VO2max) will be assessed.
Contact information is provided by the study sponsor or research team.
Korea University Anam Hospital
Other
Differences in Cardiopulmonary Exercise Capacity According to Coronary Microvascular Dysfunction and Body Composition in Patients With Suspected Heart Failure With Preserved Ejection Fraction
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06678841
Cardiovascular Diseases, Heart Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07634640
Heart Failure With Preserved Ejection Fraction (HFpEF)
Gainesville, Florida, United States
View Trial DetailsNCT07560436
Arterial Occlusive Diseases, Arteriosclerosis
London, United Kingdom
View Trial DetailsNCT06768437
Body Weight, Cardiovascular Diseases
Leicester, Leicestershire, United Kingdom
View Trial Details